PTPRN2 and breast carcinoma: PTPRN2 is a protein tyrosine phosphatase receptor, which was found to be upregulated in metastatic breast cancer and could promote cancer metastasis through PI(4,5)P2-dependent actin remodeling (Sengelaub et al., 2016).